A single dose model of methamphetamine-induced neurotoxicity in rats: effects on neostriatal monoamines and glial fibrillary acidic protein

被引:98
作者
Fukumura, M
Cappon, GD
Pu, CF
Broening, HW
Vorhees, CV
机构
[1] Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA
关键词
methamphetamine; dopamine; serotonin; neurotoxicity; hyperthermia; rat; tyrosine hydroxylase; glial fibrillary acidic protein; Western blot;
D O I
10.1016/S0006-8993(98)00656-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The neurotoxic effects of a single administration of methamphetamine (MA) were studied under conditions conducive to MA-induced hyperthermia. After a single dose of MA (10, 20, 30, or 40 mg/kg, s.c.) or saline (3 ml/kg) to Sprague-Dawley CD rats, rectal temperatures were monitored for 9 h in a room with an ambient temperature of 22.0 +/- 0.5 degrees C. MA induced significant dose-dependent hyperthermia, however, no significant increase in mortality occurred. Neostriatal DA, 5-HT, TH, and GFAP were assayed 3 days following treatment. MA induced dose-dependent reductions of DA, 5-HT and TH, and increased GFAP. For DA, at doses of 20, 30, or 40 mg/kg the reductions were to 71%, 49%, and 29%, and for 5-HT were to 73%, 44%, and 19% of control values. No reductions were seen after the 10 mg/kg dose. Semiquantitative analysis Western blots of TH and GFAP demonstrated that TH was reduced to 52%, 75%, and 28%, and GFAP was increased to 125%, 134%, and 149% of control values at MA doses of 20, 30, or 40 mg/kg, respectively. No significant changes in TH or GFAP were seen at the 10 mg/kg MA dose. These results demonstrate that a single-dose of MA can be as effective as the widely used four-dose every 2 h regimen, Moreover, mortality can be minimized by monitoring core body temperature and preventing MA-induced hyperthermia from exceeding 41.5 degrees C. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 28 条
  • [1] AGEEL AM, 1984, JAPAN J PHARM, V37, P137
  • [2] [Anonymous], [No title captured]
  • [3] EFFECTS OF A HIGH-DOSE TREATMENT OF METHAMPHETAMINE ON CAUDATE DOPAMINE AND ANOREXIA IN RATS
    BITTNER, SE
    WAGNER, GC
    AIGNER, TG
    SEIDEN, LS
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1981, 14 (04) : 481 - 486
  • [4] EFFECTS OF A COLD ENVIRONMENT OR AGE ON METHAMPHETAMINE-INDUCED DOPAMINE RELEASE IN THE CAUDATE PUTAMEN OF FEMALE RATS
    BOWYER, JF
    GOUGH, B
    SLIKKER, W
    LIPE, GW
    NEWPORT, GD
    HOLSON, RR
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 44 (01) : 87 - 98
  • [5] BOWYER JF, 1994, J PHARMACOL EXP THER, V268, P1571
  • [6] BOWYER JF, 1992, J PHARMACOL EXP THER, V260, P817
  • [7] Cappon GD, 1996, SYNAPSE, V24, P173, DOI 10.1002/(SICI)1098-2396(199610)24:2<173::AID-SYN9>3.3.CO
  • [8] 2-6
  • [9] Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response
    Cappon, GD
    Morford, LL
    Vorhees, CV
    [J]. DEVELOPMENTAL BRAIN RESEARCH, 1997, 103 (02): : 155 - 162
  • [10] CLAUSING P, 1995, J PHARMACOL EXP THER, V274, P614